Morgan Stanley keeps Moderna at equal weight
Morgan Stanley maintained its equal-weight rating on Moderna, according to Benzinga’s ratings-action recap.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Morgan Stanley raises Moderna price target to $89, keeps Equal Weight
Morgan Stanley raises its price target on Moderna to $89 from $39 and maintains an Equal Weight rating.